Study Stopped
inclusion rate too low
Efficacy of a Foot Strengthening Protocol on Sport Performance Kinetics
PRP-Pied-PERF
2 other identifiers
interventional
30
1 country
1
Brief Summary
This randomized controlled trial aims to explore the effect of a foot strengthening protocol on toe flexion strength, foot deformation and morphology as well as kinetics during sprinting, cutting and jumping in healthy athletes (18-40 completed years). The study consists of a 4 weeks control period, followed by 8 weeks intervention period and 4 weeks follow up
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 3, 2022
CompletedFirst Posted
Study publicly available on registry
October 10, 2022
CompletedStudy Start
First participant enrolled
February 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 14, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 13, 2024
CompletedSeptember 19, 2024
September 1, 2024
1 year
October 3, 2022
September 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
maximal isometric joint flexion muscle strength MTP (in N)
It will be measured using an ergometer composed of a 3-dimensional force sensor (Nano 25, ATI Industrial Automation, Garner, NC) during the 3 periods of the randomized controlled trial (control, intervention and follow-up) and repeatedly each week during the intervention protocol.
Change from baseline to Week 18
Secondary Outcomes (7)
Foot deformity
Change from baseline to Week 18
Foot posture
Change from baseline to Week 18
Morphology of the foot muscles
Change from baseline to Week 18
general stiffness of the foot-ankle complex
Change from baseline to Week 18
propulsion impulse during sprinting
Change from baseline to Week 18
- +2 more secondary outcomes
Study Arms (2)
Training group (PRP)
EXPERIMENTALParticipants benefiting from an 8-week muscle strengthening program (PRP)
Control group
SHAM COMPARATORParticipants in the control group will be asked to maintain their habits and lifestyle (without training program) for the duration of the study.
Interventions
This interventional group will perform the foot strengthening protocol (PRP) with physical tests as : * Maximum muscle strength of the foot * Foot muscle morphology
The control group will not perform the foot strengthening protocol and will continue with all their daily activities with no change in lifestyle.
Eligibility Criteria
You may qualify if:
- To be affiliated in the federation of one of the following sports : soccer, handball, rugby, basketball or track and field;
- To practice their respective sport more than two times per week;
- Be affiliated or beneficiary of a social security insurance;
- Having freely given their written consent after having been informed of the purpose, the procedure and the potential risks involved.
- Licensed in a tennis club (FFT) and in a volleyball club (FFVolley)
You may not qualify if:
- Use of pharmacological therapy to match gander identity;
- Have an abnormal range of motion of the toes and/or ankle;
- Have any kind of ankle or foot pain (self-defined and self-reported by the FAAM questionnaire) in the previous 6 months;
- Have a previous injury or surgery of the lower limb in the previous 6 months;
- Have a neurological or vestibular deficit that may affect walking or balance (lumbar-sacral radiculopathy, peripheral nerve pathology, Marfan or Eehlers-Danlos syndrome, etc.);
- Have contraindication to neuromuscular electrical stimulation (pacemaker, seizure disorders, pregnancy);
- Have a previous foot strengthening experience in the past 6 months for at least 2 weeks and more than one session per week;
- Participate at the same time in another medical interventional experiment or have participated in such a study in the 30 days preceding this study;
- Being unable to understand the purpose and conditions of the study, and to give consent;
- Being deprived of liberty or under guardianship.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Saint-Etienne
Saint-Etienne, 42055, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pascal EDOUARD, PhD
Centre Hospitalier Universitaire de Saint Etienne
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The RCT is divided into 3 distinct periods (see study diagram in Appendix 1): a 4-week control period, an 8-week intervention period and a 4-week follow-up period. This 3-period experimental design was designed to was designed to reduce various methodological biases
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 3, 2022
First Posted
October 10, 2022
Study Start
February 3, 2023
Primary Completion
February 14, 2024
Study Completion
June 13, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share